Mgp Ingredients (MGPI) Cash & Equivalents (2010 - 2026)

Mgp Ingredients (MGPI) has 16 years of Cash & Equivalents data on file, last reported at $10.4 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $10.4 million, down 48.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.4 million (down 48.5% YoY), and the FY2025 annual result was $18.5 million, down 26.96% from the prior year.
• Cash & Equivalents retreated to $10.4 million in Q1 2026 per MGPI's latest filing, from $18.5 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $50.7 million in Q3 2022 and troughed at $10.4 million in Q1 2026.
• A 5-year average of $25.3 million and a median of $21.0 million in 2024 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2023: Cash & Equivalents jumped 213.54% in 2022, then slumped 61.6% in 2023.
• A 5-year view of Cash & Equivalents shows it stood at $47.9 million in 2022, then tumbled by 61.6% to $18.4 million in 2023, then soared by 37.44% to $25.3 million in 2024, then declined by 26.96% to $18.5 million in 2025, then sank by 43.89% to $10.4 million in 2026.
• Business Quant data shows MGPI's Cash & Equivalents at $10.4 million in Q1 2026, $18.5 million in Q4 2025, and $13.4 million in Q3 2025.